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The present paper was designed to investigate the eﬀect of pine pollen against aging in human diploid ﬁbroblast 2BS cells and
in an accelerated aging model, which was established by subcutaneous injections with D-galactose daily for 8weeks in C57BL/6J
mice. Pine pollen (1mg/mL and 2mg/mL) is proved to delay the replicative senescence of 2BS cells as evidenced by enhanced
cell proliferation, decreased SA-β-Gal activity, and reversed expression of senescence-associated molecular markers, such as p53,
p21Waf1,p 1 6 INK4a, PTEN, and p27Kip1 in late PD cells. Besides, pine pollen reversed D-galactose-induced aging eﬀects in neural
activity and inﬂammatory cytokine levels, as indicated by improved memory latency time and reduced error rate in step-down test
and decreased concentrations of IL-6 and TNF-α in model mice. Similar to the role of AGEs (advanced glycation endproducts)
formation inhibitor aminoguanidine (AG), pine pollen inhibited D-galactose-induced increment of AGEs levels thus reversed
the aging phenotypes in model mice. Furthermore, the declined antioxidant activity was obviously reversed upon pine pollen
treatment, which may account for its inhibitory eﬀect on nonenzymatic glycation (NEG) in vivo. Our ﬁnding presents pine pollen
as an attractive agent with potential to retard aging and attenuate age-related diseases in humans.
1.Introduction
RodentchronicallyinjectedwithD-galactosehasbeenwidely
used as an animal aging model for brain aging or antiag-
ing pharmacology research [1–4]. An increased level of ad-
vanced glycation endproducts (AGEs) is thought to account
at least partially for the underlying mechanism as the
AGEs inhibitor aminoguanidine (AG) could block most of
the aging phenotypes in the D-galactose-induced mouse
model [5]. AGEs are a heterogeneous group of reaction
productsthatformbetweenaprotein’sprimaryaminogroup
and a carbohydrate-derived aldehyde group by reducing
sugars, such as D-glucose and D-galactose, by nonenzymatic
glycation (NEG) in vitro and in vivo [6]. Accumulating
evidence indicates that AGEs exacerbate and accelerate aging
process and contribute to the early phases of age-related
diseases, including neurodegenerative disease, cataract, renal
failure, arthritis, and age-related macular degeneration [7–
9]. Moreover, AGEs and their precursors usually contain
reactive carbonyl groups, which can be generated by the
actions of reactive oxygen species (ROS) [10, 11].
As a kind of Chinese traditional medicine, pine pollen,
which is the male spore of pine tree, has been used as a drug
and food for thousands of years. Pine pollen has an eﬀect in
the treatment of diﬀerent kinds of diseases such as colds, dis-
ease of the prostate, anemia, diabetes, hypertension, asthma,
and rhinitis [12–14]. Pine pollen is collected artiﬁcially from
PinusmassonianaLamb.,PinustabulaeformisCarr.,andithas
the characteristics of a single pollen source, pure quality, and
is a stable component. Pine pollen powder, called “natural
micronutrient storeroom,” is rich in many kinds of body-
demanding amino acid, minerals, vitamin, enzyme, and ﬂa-
vonoids [12]. Although it is well proposed that pine pollen
may have antiaging eﬀect due to its various beneﬁts on˜hu-
man health, the direct supportive experimental evidence
linking the drug with aging has rarely been reported so
far. So, it is interesting to investigate whether pine pollen
possesses any antiaging eﬀect in vitro and in vivo.2 Oxidative Medicine and Cellular Longevity
Here,theantiagingeﬀectofpinepolleninvitrowasﬁrstly
investigatedbyusingthehumandiploidﬁbroblasts(2BS)cell
line, which has been well characterized and widely used as a
cellularsenescencemodel[15–17].Then,theaccelerateaging
model in mice induced by D-galactose was used to evaluate
the eﬀect of pine pollen against aging in vivo [1, 5, 18]. We
treated a group of 5-month-old C57BL/6J mice daily with
D-galactose, D-galactose combined with various dosages
of pine pollen (500, 1000, 1500mg/kg, resp.), D-galactose
combined with AGEs formation inhibitor AG, and control
buﬀer for 8 weeks. At the end of the treatment, learning and
memory abilities, serum and cerebral AGEs levels, indicators
for antioxidant activity, and proinﬂammatory cytokines
levels were determined. Our results demonstrated that pine
pollen could retard the aging process in cells and mice thus
presents pine pollen as an attractive agent with potential to
retard aging and attenuate age-related diseases in humans.
2.MaterialandMethods
2.1. Reagents. Pine pollen was kindly provided by Zhejiang
Yalin Biotechnology Co. Ltd. (Hangzhou, China), and
was suspended with 0.5% sodium carboxymethyl cellulose
(CMC-Na) before administrating. Bovine serum albumin
(BSA), 5-bromo-4-chloro-3-indolyl-beta-D-galactoside (X-
Gal), D-galactose, and aminoguanidine hydrochloride (AG)
were purchased from Sigma-Aldrich. Elisa kits for AGEs,
interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-
α) determination were obtained from R&D Systems, USA.
Dulbecco’s modiﬁcation of Eagle’s medium (DMEM), fetal
bovine serum (FBS), and trypsin were obtained from Gibco,
USA. Kits for malondialdehyde (MDA) assay and total
superoxide dismutase (SOD) activity measurement were
purchased from Nanjing Jiancheng Bioengineering Institute
(Nanjing, China). BCA protein assay kit was from Pierce
Chemical Co, USA.
2.2. Cell Culture. The 2BS cell line isolated from human fetal
lung ﬁbroblasts was originally established by the National
InstituteofBiologicalProducts(Beijing,China)andhasbeen
well characterized and widely used as a cellular senes-cence
model[15,19].Thec ellsar ec onsider edt obey oungatearlier
than population doubling (PD) 30 and fully senescent at
PD55 or later. The cells were grown in DMEM supplement-
ed with 10% FBS, 100U/mL penicillin, and 100mg/mL
streptomycin in an incubator at 37◦Cw i t h5 %C O 2.T h e
cultured cells were split in ratios of 1:2 or 1:4 when the
conﬂuence of the culture was over 85%. The cumulative
population doublings (CPDs) were calculated as log2(D/D0),
where D and D0 are deﬁned as the density of cells at the time
of harvesting and seeding, respectively.
2.3. Cell Proliferation Monitoring. Cell proliferation was
monitored using the XCELLigence system (Roche Applied
Science, DP, Switzerland), an impedance-based nondestruc-
tive assay of cell proliferation. The presence of the cells on
top of the electrodes aﬀects the local ionic environment at
the electrode/solution interface, leading to an increase in the
electrode impedance. Increasing number of cells increases
the impedance detected, displayed as cell index (CI) values.
The accuracy of this system has previously been validated
for monitoring cell numbers over long periods of incubation
[20]. Five thousand cells were seeded in 200μLo fc e l lc u l t u r e
media in each well of a 16-well plate, in quadruplicate.
Pine pollen was supplemented at a ﬁnal concentration of
1mg/mL and 2mg/mL 24h later, and the cells were cultured
foranadditionalindicatedtime.Cellcultureconditionswere
identical to that described above, and the cell proliferation
was monitored over four days.
2.4. Senescence-Associated Galactosidase (SA-β-Gal) Staining.
2BS cells grown in DMEM with or without pine pollen
(1mg/mL and 2mg/mL) were stained according to a mod-
iﬁed method of Dimri et al. [21]. The percentage of SA-β-gal
positive cells out of the total number of cells was counted.
Average percentages were obtained from three independent
experiments.
2.5. Western Blot Analysis. 2BS cells were washed with iced
PBS and then lysed with cell lysis buﬀer containing protease
inhibitors cocktail (Cell Signaling Technology, Inc., USA).
Protein concentrations were determined by BCA protein
assay kit (Pierce Chemical Co.). Total 50μgo fp r o t e i ne x -
tracts were loaded and electrophoresed on 12% SDS poly-
acrylamide gel and transferred to the nitro cellulose mem-
brane (Bio-Red, USA). The membranes were subsequently
probed with anti-p53, anti-p16INK4, anti-p21Waf1, anti-PTEN
and anti-p27Kip1 (Cell Signaling Technology, Inc., USA), and
anti-β-actin monoclonal antibodies (Santa Cruz Biotechnol-
ogy, Inc., USA), respectively. The secondary antibody used
for detection was linked with horseradish peroxidase. The
enhanced chemiluminescence (ECL) method was used to
detect the conjugated horseradish peroxidase.
2.6. Animals and Treatment. Five-month-old C57 BL/6J fe-
male mice (Slaccas Laboratory Animal Co. Ltd. Shanghai,
China), were randomly divided into six groups of ten each.
After one week adaptation period, the animals were given
daily one of the following preparations subcutaneously
for eight weeks: (I) vehicle control; (II) D-galactose at
100mg/kg; (III) D-galactose at 100mg/kg plus pine pollen
at 500mg/kg by intragastric injection; (IV) D-galactose at
100mg/kg plus pine pollen at 1000mg/kg by intragastric
injection; (V) D-galactose at 100mg/kg plus pine pollen
at 1500mg/kg by intragastric injection; (VI) D-galactose at
100mg/kg plus AG at 100mg/kg by intragastric injection.
Mice were sacriﬁced at the end of treatment, and sera, organs
and tissues were immediately collected for experiments or
stored at −70◦C for later experiments. Sera could be used for
detection directly while tissue samples should be performed
according to the following treatment.
Tissue Homogenization: tissue samples were weighed
and homogenized in normal saline (NS) for studies, and ho-
mogenates of 5% were obtained. Tissue homogenates were
sonicated two times at 30sec, intervals. Homogenization
and sonication were performed at 4◦C. After sonication,Oxidative Medicine and Cellular Longevity 3
homogenates for biochemical studies were centrifuged at
3000rpm for 10min and at 12000rpm for 15min, respec-
tively. Aliquots of the supernatants were used for the studies.
The assayed parameters were expressed per mg protein, and
protein content of the aliquots was determined by a BCA
protein assay kit (Pierce Chemical Co.). All experimental
procedures used in this study had been approved by the
ethics committee within our hospital and all animal exper-
iments had been performed in accordance with the ethical
standards laid down in the 1964 Declaration of Helsinki.
The authors who performed experiments had given their
informed consent prior to the study and had followed
“principles of laboratory animal care” published by the
National Institutes of Health (NIH publication no. 86-23,
revised 1985).
2.7. Step-Through Test for Acquisition of Memory. We used a
step-downpassiveavoidancetesttoevaluatethelearningand
memoryabilityofmiceaccordingtothepreviousdescription
[22]. Brieﬂy, it is consisted of a transparent Plexiglas circular
cage (40cm in height, 30cm in diameter) with a grid ﬂoor
andacircularplatform(4cmdiameter)inthecenter.During
the training session, animals were placed on the platform
and their latency to step down with all four paws was meas-
ured. Immediately after stepping down on the grid, animals
received an electric shock (0.6mA, 2sec). Retention test
sessions were carried out 24h after training. Step-down la-
tency on the test day was recorded as an index of inhibitory
avoidance memory. A cut-oﬀ time of 300sec was set, and
the number of memory errors during the 5min was also
recorded.
2.8. Measurement of SOD Activity and Lipid Peroxidation in
Mouse. The activity for SOD in sera and brains was ex-
amined according to xanthine oxidase method provided by
the standard assay kit (Nanjing Jiancheng Bioengineering
Institute, China) as described [17]. The assay used the xan-
thine-xanthine oxidase system to produce superoxide ions,
which reacted with 2-(4-iodophenyl)-3-(4-nitrophenol-5-
phenlyltetrazolium chloride) to form a red formazan dye,
and the absorbance at 550nm was determined. The values
were expressed as units per mg protein, and protein concen-
tration was determined by a BCA protein assay kit (Pierce
Chemical Co.), where one unit of SOD was deﬁned as the
amount of SOD inhibiting the rate of reaction by 50% at
25◦C.
Lipid peroxidation was evaluated by measuring MDA
concentrations according to the thiobarbituric acid (TBA)
method as commercially recommended (Nanjing Jiancheng
Bioengineering Institute, China). The method was based on
the spectrophotometric measurement of the color produced
during the reaction to TBA with MDA. MDA concentrations
werecalculatedbytheabsorbanceofTBAreactivesubstances
(TBARS) at 532nm.
2.9. Protocols for Other Assays. ELISA assay for AGEs, IL-
6, and TNF-α was carried out with commercial kits (R&D
Systems, USA) according to the manufacturer’s protocol.
Table 1: The life spans of 2BS cells in CPDs, based on the actual
number of cells harvested and seeded.
Group Treatment
Time of
transfer to
special
medium
N CPDs Average PDs per
week
Ic o n t r o l — 3 5 3 .7±3.61 .7 ±0.1
II Pine pollen
(1mg/L) PD30 3 61.8±5.12 .2 ±0.2∗
III Pine pollen
(2mg/L) PD30 3 60.5±4.72 .1 ±0.1∗
Note. Cells were grown from PD30 in DMEM supplemented with pine
pollen at 1mg/L and 2mg/L, respectively. The cultured cells were split in
ratiosof1:2or1:4whentheconﬂuenceoftheculturewasreached70–80%.
CPDs (cumulative population doublings) were calculated as log2(D/D0),
where D and D0 were deﬁned as the density of cells at the time of harvesting
and seeding, respectively. The last culture was deﬁned as the subculture
that could not be conﬂuent in 3 weeks. Data were obtained from three
independent experiments (∗P<0.05, versus I).
2.10. Inhibition on AGE Formation In Vitro . AGE-modiﬁed
BSA was prepared as previously described [23]. Brieﬂy, BSA
(100mg/mL) was incubated under sterile conditions with
0.5M D-galactose in 0.2M phosphate-buﬀered saline (PBS,
pH 7.4) at 37◦C for eight weeks. For pine pollen or AG
inhibition, samples were added with pine pollen (1.2mg/mL
and 2.4mg/mL) or AG (100mM) and were incubated under
identical conditions. The control BSA sample was incubated
under identical conditions but without supplementation of
D-galactose. Samples were dialyzed (10kDa cut-oﬀ) against
PBS and then the content of BSA-AGEs was determined by a
commercial Elisa kit as described previously.
2.11. Data Analysis. All data listed in the ﬁgures or the tables
were expressed as mean ± SEM. One-way ANOVA analysis
(SPSS 15.0) was used for data comparisons within multiple
groups. In each case, P<0.05 was considered statistically
signiﬁcant.
3. Results
3.1. Eﬀects of Pine Pollen on Cumulative Population Dou-
blings in 2BS Cells. In this study, we ﬁrstly observed the
eﬀects of pine pollen on replicative lifespan and biomarkers
related to replicative senescence in human fetal lung diploid
ﬁbroblasts(2BS).Pinepollensigniﬁcantlydelayedreplicative
senescence of 2BS cells by at least 7 PDs (see Table 1). The
two concentrations of pine pollen (1mg/mL and 2mg/mL)
showed a similar gain in PDs. The growth rate of pine
pollen treatment cells was dramatically increased compared
to that of the control cells (Table 1). Meanwhile, pine pollen
improved the proliferation of 2BS cells as demonstrated by
using the Xcelligence system (Roche Applied Science, Basel,
Switzerland), an impedance-based nondestructive assay of
cellproliferation.CellsatPD30incubatedwithpinepollenat
1mg/mL and 2mg/mL for 24–48h showed a maximum 20%
elevation on cell index (CI) compared with that of control
(Figure 1).4 Oxidative Medicine and Cellular Longevity
Table 2: Body weight and AGEs Levels.
Group Treatment
Body weight
Serum AGEs (ng/mL) Cerebral AGEs (ng/mg
prot) Pretreatment Posttreatment
I Young control 22.83 ±1.13 25.32 ±1.15 145.34 ±47.73 24.71 ±23.42
II D-gal (100mg/kg) 22.62 ±0.98 23.93 ±0.98 294.65 ±165.93∗ 53.46 ±29.57∗
III D-gal + PP (500mg/kg) 22.37 ±0.80 23.28 ±1.00 163.47 ±158.04 31.46 ±14.86
IV D-gal + PP (1000mg/kg) 21.84 ±0.93 22.99 ±1.42 201.69 ±118.65 31.67 ±18.65
V D-gal + PP (1500mg/kg) 22.13 ±1.46 23.52 ±1.80 202.08 ±158.40 27.71 ±19.06
VI D-gal + AG (100mg/kg) 22.32 ±1.32 24.63 ±2.05 158.29 ±101.17 23.88 ±19.17
Note. C57BL/6J female mice (5-month-old, n = 10 in each group) were treated daily with PBS (s.c, young control), D-galactose (D-gal, 100mg/kg, s.c), D-
gal (100mg/kg, s.c) with pine pollen (PP, 500, 1000, 1500mg/kg, ig) and aminoguanidine (AG, 100mg/kg, ig). AGEs levels at the end of the treatment were
determined by a quantitative AGEs-ELISA kit. Statistical signiﬁcant diﬀerence: ∗P<0.05, versus I; P<0.05, versus II.
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Figure 1: Line graph showing result of impedence-based cell
proliferation assay (Xcelligence). The cell index (see Section 2)w a s
plotted against time for the 2BS cells. Pine pollen (PP) was added
24haftercell-seeding,andanapprox.20%elevationcomparedwith
the control was observed between 24–48h under PP (1mg/mL and
2mg/mL) incubation.
3.2.EﬀectsofPinePollenonSA-β-GalActivityin2BSCells. As
expected, only sporadic SA-β-gal positive cells were observed
in young control cells. As shown in Figure 2, the SA-β-
gal positive rates of 1mg/mL and 2mg/mL pine pollen
treatment PD55 cells were 27.2 ± 4.3% and 25.3 ± 4.9%,
respectively, which were much lower than that of PD55
control cells (81.7 ± 7.1%). These results indicate indirectly
thatthepinepollendelayedthepopulationsenescenceof2BS
cells.
3.3. Eﬀects of Pine Pollen on Expression of Senescence Associ-
ated Molecules in 2BS Cells. Activation of p53-p21 and p16-
Rb pathways results in replicative cellular senescence in
human diploid ﬁbroblasts [17, 24] .S i m i l a rt oo u rp r e v i o u s
experiment, an elevated protein level of cyclin-dependent
kinase(CDK)inhibitorsp21Waf1 andp16INK4 wasobservedin
control late PD 2BS cells. However, the increased expression
of senescence-associated molecules p53, p21, and p16 in late
PD 2BS cells were signiﬁcantly reversed to that of young
control after pine pollen treatment (Figure 3). Moreover,
emerging evidence revealed that the tumor suppressor phos-
phatase and tensin homolog PTEN and its downstream
eﬀector p27Kip1 are also critical for replicative senescence
[24,25].Thustheeﬀectofpinepollenonthissignalingpath-
way was also checked in current experiment. Western blot
results indicated that the protein expression of PTEN and
p27Kip1 was downregulated upon pine pollen treatment in
late PD 2BS cells (Figure 3).
3.4. Eﬀects of Pine Pollen on AGEs Formation in Mice. The
facts that pine pollen retarding the aging process in 2BS
cells promoted us to detect whether pine pollen has any
antiaging eﬀect on the D-galactose-induced aging model.
Indeed,withintheperiodofpinepollentreatment,nomouse
showed a signiﬁcant abnormality that could be detected
by visual examination. All groups of mice gained weight
normally throughout the study (Table 2). As expected, mice
treatedwithD-galactoseshowedaremarkablyincreasedlevel
of serum and cerebral AGEs compared with control ones
(P<0.05, Group II versus Group I, see Table 2), and
AG, a well-accepted AGEs formation inhibitor, signiﬁcantly
reversed the elevation of serum and cerebral AGEs in D-
galactose-treated mice (P<0.05, Group VI versus Group II,
seeTable 2).Itshouldbenotedthatamongthethreediﬀerent
doses of pine pollen, low dosage (500mg/kg) treatment
showed best eﬃcacy, which signiﬁcantly blocked the increase
ofserumAGEsin D-galactose-treatedmice(P<0.05, Group
III versus Group II, see Table 2). Although a dose-dependent
inhibitory eﬀect of pine pollen on cerebral AGEs formation
was observed in D-galactose-treated mice, the in vitro assay
suggested that pine pollen had little inhibitory eﬀect on the
BSA-AGEs formation (Figure 4).
3.5. Eﬀects of Pine Pollen on Neurological Activities in Mice.
Next,wetestedwhetherthedecrementofserumandcerebral
AGEs induced by pine pollen would reverse any aging eﬀects,
such as neurological activities, in D-galactose-induced aging
model. Learning and memory abilities were examined by
step-down test. D-galactose treatment signiﬁcantly lowered
the learning and memory activity of young mice compared
with controls as evidenced by shortened latency of step-
down and elevated number of memory errors within ﬁve
minutes. Consistent with previous studies [5], the loweredOxidative Medicine and Cellular Longevity 5
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Figure 2: SA-β-gal staining of 2BS cells grown from PD30 in DMEM supplemented with 1mg/mL or 2mg/mL pine pollen (PP). Cells of
none-conﬂuent state were washed with PBS, ﬁxed with 3% formaldehyde, and stained in staining solution containing 1mg/mL 5-bromo-4-
chloro-3-indolyl-β-D-galactoside for 16h. 2BS cells at PD30 were set as young control. Cells were microphotographed at a magniﬁcation of
10 × 10. ∗P<0.01 versus 30PD control group; #P<0.01 versus 55PD control group.
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Figure 3: (a) Protein levels of p53, p21, p16, PTEN, and p27 in 2BS cells grown from PD30 in DMEM supplemented with 1mg/mL or
2mg/mL pine pollen (PP). Representative images were acquired from three diﬀerent experiments. (b) Quantitative analysis of the protein
levels of p53, p21, p16, PTEN, and p27. Bars represent relative protein levels counted as D1/D0 (the value for PD30 control was set as 1.0),
where D0a n dD1 stand for the optical density of β-actin ladder and sample ladder, respectively. The optical density for each ladder was
calculated by Image J soft ware. Data were obtained from three independent experiments. ∗P<0.05 versus 30PD control group; #P<0.05
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Table 3: Eﬀect of pine pollen on SOD activity and MDA levels in mice.
Group Treatment Serum MDA
(nmol/mL)
Cerebral MDA
(nmol/mg prot) Serum SOD (U/mL) Cerebral SOD (Ul/mg prot)
I Young control 7.74 ±1.04 1.17 ±0.45 82.91 ±4.25 128.98 ±17.78
II D-gal (100mg/kg) 17.66 ±7.93∗∗ 2.90 ±1.28∗∗ 69.18 ±6.00∗ 91.36 ±19.83∗
III D-gal + PP (500mg/kg) 9.27 ±0.89 1.73 ±0.59 79.06 ±2.36 109.27 ±12.91
IV D-gal + PP (1000mg/kg) 10.69 ±2.44 1.64 ±0.39 77.73 ±2.65 110.76 ±24.02
V D-gal + PP (1500mg/kg) 9.14 ±4.07 1.51 ±0.22 78.64 ±2.44 111.71 ±16.59
VI D-gal + AG (100mg/kg) 5.89 ±2.65 1.48 ±0.24 79.80 ±2.75 120.88 ±25.91
Note. C57BL/6J female mice (5-month-old, n = 10 in each group) were treated daily with PBS (s.c, young control), D-galactose (D-gal, 100mg/kg, s.c), D-
gal (100mg/kg, s.c) with pine pollen (PP, 500, 1000, 1500mg/kg, ig), and aminoguanidine (AG, 100mg/kg, ig). SOD and MDA level in sera and brains were
determinedbycommercialkits(NanjingJianchengBioengineeringInstitute,China)accordingtothemanufacturer’sprotocol.Statisticalsigniﬁcantdiﬀerence:
∗P<0.05, versus I; P<0.05, versus II; ∗∗P<0.01, versus I; P<0.01, versus II.
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Figure 4: Eﬀect of pine pollen on the BSA-AGEs formation in vitro.
BSA alone at 100mg/mL (I), BSA plus D-galactose at 0.5M (II),
BSA plus D-galactose and pine pollen (1.2mg/mL and 2.4mg/mL,
III and IV), and BSA plus D-galactose and AG at 100mM (V) were
incubated at 37◦C for eight weeks under sterile conditions. Samples
were dialyzed (10kDa cut-oﬀ) against PBS and then the content of
BSA-AGEs was determined by a commercial Elisa kit as described
in Section 2. Data were results of three parallel experiments and
were expressed as mean± SEM. Statistical signiﬁcant diﬀerence:
∗P<0.01, versus I; #P<0.01, versus II.
learning and memory activity of model mice can be reversed
byAGtreatment(Figure 5).Theelevatednumberofmemory
errors within ﬁve minutes in D-galactose-treated young
mice was also prevented by pine pollen treatment. Similarly,
pine pollen reversed the shortened latency of step-down
in D-galactose-treated mice. Noticeably, the high dosage
(1500mg/kg) of pine pollen exhibited a comparable eﬀect to
that of AG treatment (see Figure 5).
3.6. Eﬀect of Pine Pollen on Proinﬂammatory Cytokines Levels
in Mice. It is well documented that aging is associated with
increased circulating levels of proinﬂammatory cytokines.
Increased levels of inﬂammatory serum markers in the
elderly are associated with neurodegenerative diseases, such
as dementia, Parkinson’s disease [26]. As shown in Figure 6,
the TNF-α and IL-6 levels in serum and cerebral were signif-
icantly elevated in D-galactose-treated mice in comparison
to those in control group. Notably, pine pollen treatment
signiﬁcantly prevented the increment of cerebral IL-6 which
was comparable to that of AG treatment. A decreased trend
of TNF-α level in sera and brains was also observed upon
pine pollen treatment in model mice, though the diﬀerence
was not statistically signiﬁcant.
3.7. Eﬀects of Pine Pollen on the Antioxidant Enzymes Activity
and Lipid Peroxidation in Mice. It has been reported that
D-galactose treatment resulted in an elevation of oxidative
stress both in vivo and in vitro [2, 27]. As expected, SOD
activity was decreased, while the MDA level, an indicator
of lipid peroxidation, increased in serum and brain in D-
galactose-treatedyoungmice.However,additionaltreatment
of pine pollen resulted in the increase of cerebral SOD
activityandremarkabledecreaseofserumandcerebralMDA
level in D-galactose treated mice (see Table 3). Consistent
with previous study [5], a potent reversible eﬀect of AG
on SOD and MDA in this aging model was also observed
(Table 3).
4. Discussion
Human diploid ﬁbroblast cells can divide for only a limited
number of times in vitro, a phenomenon known as replica-
tive senescence [28] .T h ep h e n o t y p e so fs e n e s c e n t2 B Sc e l l s
included morphological changes, lower cell proliferation,
positive SA-β-gal staining [16], and G1 cycle arrest which
was mainly resulted from elevated protein levels of cyclin-
dependent kinase (CDK) inhibitors p21Waf1 and p16INK4
[17]. Thus, we chose these senescence-associated markers to
evaluate the antiaging eﬀect of pine pollen in the current
study. Our results demonstrated that Pine pollen delayed
the replicative senescence of 2BS cells as evidenced by en-
hanced cell proliferation, decreased SA-β-Gal activity, and
reversed expression of p53, p21, and p16 molecules in late
PD cells (Figures 1, 2,a n d3). Meanwhile, the expression of
PTEN-p27Kip1 was also attenuated upon pine pollen treat-
ment, which further supported our conclusions. The dosagesOxidative Medicine and Cellular Longevity 7
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Figure 5: Latency time (a) and memory error rates (b) of young control (I), D-galactose alone(100mg/kg) treated (II), D-galactose
combined with pine pollen (500, 1000, 1500mg/kg) treated (III, IV, V), and D-galactose combined with AG (100mg/mg) treated (VI)
mice. The step-down method was used to determine the latency time and memory error rates. Each mouse was trained for 5min ﬁrst to
“remember” the system. Twenty-four hours later, mice were placed in the same cage and latency time (second), and the number of errors
within ﬁve minutes was recorded. Data were results of ten animals for each group and expressed as mean ± SEM. Statistical signiﬁcant
diﬀerence: ∗P<0.05, versus I; #P<0.05, versus II.
of pine pollen (1mg/mL & 2mg/mL) used in this study
were much higher than that in previous studies (10μg/mL)
[14] as they used the ethanol extract of pine pollen (PPE),
which was diﬀerent from ours. We used the pine pollen
powder rather than its extract. Since the abundance of active
substancesinourmaterialswaslowerthanthatoftheethanol
extract of pine pollen, higher dosages have to be used in our
experiment. However, the cell toxicity of pine pollen among
0∼5mg/mL was undetectable in 2BS cells according to an
MTT assay (see Figure 7).
Though pine pollen showed an antiaging eﬀect in
vitro, whether it possesses any eﬀect against aging in vivo
remains elusive. Here we selected an accelerated aging model
induced by D-galactose for the in vivo study as this model
resembles their aged control counterparts (16- to 24-month-
old) both physiologically and pathologically and has been
widely used for antiaging pharmacology research [1, 29, 30].
Our previous study demonstrated that D-galactose injection
led to an accelerated aging phenotypes manifested by an
increased serum AGEs level [5, 18]. Treatment of AGEs
formation inhibitor aminoguanidine (AG) and salidroside
in D-galactose-induced aging mice could block most of the
aging phenotypes, indicating that AGEs may account at least
partially for the mechanism of the accelerated aging [5, 18].
In current experiment, the pine pollen showed diﬀerent
inhibitory eﬀect on serum and cerebral AGEs formation
in model mice. When the model mice were treated with a
high dosage (1500mg/kg) of pine pollen, the lowest level
of AGEs in brains and a best reversal eﬀect on lowered
neurological activity were observed (Figure 5). However,
pine pollen at a lower dosage (500mg/kg) exhibited a best
inhibitory eﬃcacy on serum AGEs generation rather than
the other two higher doses (1000mg/kg and 1500mg/kg).
Besides, the in vitro assay revealed that pine pollen had
little inhibitory eﬀect on the BSA-AGEs formation, which
was diﬀerent from the role of AG, as this compound could
inhibit the nonenzymatic glycation (NEG) both in vivo and
in vitro (Table 2 and Figure 4). The possible reasons for
the diﬀerent role between pine pollen and AG were listed
as below. Firstly, pine pollen contains various ingredients,
including proteins, vitamins, enzymes and coenzymes, fats,
ﬂavonoids, nucleic acids, monosaccharides, polysaccharides,
phospholipids, and other nutrients [12]. Flavonoids have
been reported as potent inhibitors on AGEs formation [31,
32], while the ingredients of protein and monosaccharides
are the substrates of nonenzymatic glycation which may
accelerate the AGEs formation. Thus the inhibitory eﬀect
of pine pollen on AGEs formation would be partly oﬀset
by itself. Since higher dosages of pollen contain more non-
enzymatic glycation substrates, a better inhibition of pine
pollenonserumAGEsformationdisplayedunderlowdosage
rather than that of higher dosages in vivo. Secondly, pine
pollenshowedanoptimal inhibition oncerebralAGEsunder
high dose (1500mg/kg); this may be induced by more active
substances such as ﬂavonoids in pine pollen going through
into brain tissues. Thirdly, pine pollen may indirectly inhibit
the AGEs formation in vivo by an antioxidant mechanism.
Increased AGEs level can induce an elevated level of intracel-
lular oxidative stress levels, which in turn promotes the non-
enzymatic glycation [11, 33]. Eﬀective removal of reactive
oxygen species (ROS) may block the formation of AGEs.
Indeed, the D-galactose-treated mice showed an elevation of
oxidative stress in our experiment, and it was signiﬁcantly
reduced by pine pollen, as indicated by the declined MDA
concentration, and reversion of decreased SOD activity
(Table 3).
On the other hand, aging is associated with increased
circulating levels of pro-inﬂammatory cytokines [26], which
at least partly results from the increment of AGEs in elder
persons as AGEs increase inﬂammation through binding8 Oxidative Medicine and Cellular Longevity
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Figure 6: Proinﬂammatory cytokines levels of young control (I), D-galactose alone (100mg/kg) treated (II), D-galactose combined with
pine pollen (500, 1000, 1500mg/kg) treated (III, IV, V), and D-galactose combined with AG (100mg/mg) treated (VI) mice. IL-6 and TNF-
α in sera and brains were determined by quantitative ELISA kits. Data were results of ten animals for each group and expressed as mean ±
SEM. Statistical signiﬁcant diﬀerence: ∗P<0.05, versus I; #P<0.05, versus II.
with the receptor for AGEs (RAGEs). Inﬂammatory medi-
ators that are upregulated through AGEs pathway include
TNF-α, IL-6, and C-reactive protein [34]. Thus a reduction
of TNF-α and IL-6 in our model mice treated with pine
pollenwaspartlyduetoitsinhibitoryeﬀectonnonenzymatic
glycationasasimilarresultinmodelmicetreatedbythewell-
accepted AGEs inhibitor AG was also observed (Figure 6).
However, our study might be limited by several aspects.
As pine pollen is a complex mixture, it is necessary to clarify
which kind of composition in pine pollen is responsible for
its NEG inhibitory activity, and thus this beneﬁcial eﬀect
could be optimized by using corresponding extraction from
pinepollen.Furtherworkregardingtherelationshipbetween
the NEG inhibitory activity and antioxidant property of this
drug is also needed.
5. Conclusions
Taken together, pine pollen is proved to delay the replicative
senescence of human diploid ﬁbroblasts and block D-gal-
actose-induced increase of serum and cerebral AGEs level
in model mouse, which may result in the reversal of D-
galactose-inducedagingeﬀectsinbothneuralandinﬂamma-
tion system. It is possible that pine pollen exerts its antiagingOxidative Medicine and Cellular Longevity 9
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Figure 7: The cell toxicity of pine pollen was evaluated by the
cell proliferation detected by the MTT assay. In brief, the 2BS cells
were seeded in ﬂat-bottomed 96-well microplates at the density of
3000 cells in 0.2mL per well. After 20h, the cells were incubated
in the culture medium containing various concentrations of pine
pollen (PP) for 48h.Then 20μL MTT [3-(4,5)-dimethylthiahiazo
(-z-y1)-3,5-diphenlytetrazoliumbromide] of 10mg/mL was added
to each well. After incubation for 4h, 0.2mL DMSO was added
to stop reactions. The absorbance values of each well were
determined spectrophotometrically at 570nm using the microplate
reader (BIOTEK, Rockville, MA, USA). A stimulatory rather than
inhibitory eﬀect of pine pollen under 0.5–5mg/mL on 2BS cell
proliferationwasobserved,whichindicateditsbiosafetyundersuch
dosages.
eﬀects at least partially by its NEG-inhibiting eﬀect in vivo.
Our work ﬁrst directly proves the antiaging eﬃcacy of the
natural agent both in vivo and in vitro and thus inspires the
new application for this drug in gerontological area.
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